Search
for
Sort by
Research 31–60 of 180
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Dermatologic Reactions to Targeted Therapy
- Erosive Pustular Dermatosis of the Scalp
- Management of Toxicities of Targeted Therapies
- A prospective observational study on drug safety monitoring and Pharmacoeconomics in patients with locally advanced unresectable NSCLC in a tertiary care hospital
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Drug-Induced Skin, Nail and Hair Disorders
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Anagen effluvium
- Hair disorders in patients with cancer
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Alopecia With Endocrine Therapies in Patients With Cancer
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Redefining hormone resistance in prostate cancer
- Alternative uses of dermoscopy in daily clinical practice: An update
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Hair loss in elderly women
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Alopecia in Association with Malignancy: A Review
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Hypothyroidism in Thyroid Carcinoma Follow-up: Orlistat May Inhibit the Absorption of Thyroxine
- An Update on Drug-Induced Pigmentation
- Green tea in dermatology - myths and facts
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Erosive pustular dermatosis of the scalp: causes and treatments
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs